PUSHPA SINGH: Open Payments
NPI 1851830285 · WAYCROSS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,153 in 97 payments from 17 companies in 2025. Trend: 2023 $1,837 · 2024 $1,632 · 2025 $2,153
Food & beverage: $2,073Education: $80
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 23 | $560 |
| ABBVIE INC. | 17 | $366 |
| Janssen Biotech, Inc. | 10 | $300 |
| Amgen Inc. | 16 | $292 |
| Novartis Pharmaceuticals Corporation | 7 | $142 |
| Mallinckrodt Hospital Products Inc. | 6 | $109 |
| GlaxoSmithKline, LLC. | 4 | $84 |
| Radius Health, Inc. | 2 | $50 |
| ANI Pharmaceuticals, Inc. | 2 | $40 |
| KYOWA KIRIN, INC. | 2 | $39 |
Products named: Bimzelx, TREMFYA, RINVOQ, COSENTYX, SKYRIZI, OTEZLA, ACTHAR, BENLYSTA.
Industry payments across GA — which companies pay providers there.
